Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
United States
Insulin glargine

FDA 2019

Insulin glargine

Basaglar

300UNITS/3ML InjectionUnited StatesMarketedAuthorised 15 Nov 2019

Open in the registerAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

BasaglarBrazil · Eli Lilly do Brasil LtdaSame brand
BasaglarCanada · 100 UNIT / ML · Solution · Eli Lilly Canada INCSame brand
BasaglarCanada · 100 UNIT / ML · Solution · Eli Lilly Canada INCSame brand
BasaglarCanada · 100 UNIT / ML · Solution · Eli Lilly Canada INCSame brand
BASAGLAR 100 u/ml Solution For Injection In cartridgeSaudi Arabia · Lilly FranceSame brand
BASAGLAR 100 u/ml Solution For Injection In Pre-Filled PenSaudi Arabia · Lilly FranceSame brand
BASAGLAR 100 u/ml solution for injection in Pre-Filled pen

More with the same substance on this register

BasaglarInsulin glargine · 300 UNITS/3ML · solutionUnited States
RezvoglarInsulin glargine · 3ML · injectableUnited States

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Saudi Arabia · Eli Lilly

Same brand

🇪🇸Abasaglar 100 Unidades/ML Kwikpen Solucion Inyectable en Pluma PrecargadaSpain · 100 U · solución inyectable en pluma precargada · Eli Lilly Nederland B.V.Same form

🇪🇸Lantus 100 Unidades/ML Solucion Inyectable en Un CartuchoSpain · 100 UI · solución inyectable en cartucho · Sanofi-Aventis Deutschland GmbhSame form

🇪🇸Lantus 100 Unidades/ML Solucion Inyectable en Un VialSpain · 100 UI · solución inyectable · Sanofi-Aventis Deutschland GmbhSame form

🇮🇹AbasaglarItaly · Soluzione iniettabile · Eli Lilly Nederland B.V.Same form

🇮🇹LantusItaly · Soluzione iniettabile · Sanofi-Aventis Deutschland GMBHSame form

🇮🇹OndibtaItaly · Soluzione iniettabile in penna pre-riempita · Gan & Lee Pharmaceuticals Europe GMBHSame form

🇳🇱ABASAGLAR 100 E/ml, oplossing voor injectie in een patroonNetherlands · Oplossing voor injectie · Eli Lilly Nederland B.V.Same form

🇳🇱ABASAGLAR 100 E/ml, oplossing voor injectie in een voorgevulde penNetherlands · Oplossing voor injectie · Eli Lilly Nederland B.V.Same form

🇳🇱Lantus 100 eenheden/ml oplossing voor injectie in een injectieflaconNetherlands · Oplossing voor injectie · Sanofi-Aventis Deutschland GmbHSame form

🇳🇿LantusNew Zealand · Inj 100 u per ml, 10 mlSame form

🇳🇿LantusNew Zealand · Inj 100 u per ml, 3 mlSame form

🇳🇿LantusNew Zealand · Inj 100 u per ml, 3 ml cartridgeSame form

🇷🇴AbasaglarRomania · 100UI/ml · sol inj. · Eli Lilly Nederland B.V.Same form

🇷🇴LANTUS 100U/mlRomania · 100U/ml · sol. inj. in cartus · SanofiSame form

🇷🇴LANTUS SoloStarRomania · 100U/ml · sol. inj. in stilou injector preumplut · SanofiSame form

🇷🇸Lantus® SoloStar®Serbia · 100j./mL · rastvor za injekciju u napunjenom injekcionom penu · Amicus SRB D.O.O.Same form

🇷🇸Semglee®Serbia · 100j./mL · rastvor za injekciju u napunjenom injekcionom penu · Evropa Lek Pharma D.O.O. BeogradSame form

🇷🇸Toujeo®Serbia · 300j./mL · rastvor za injekciju u napunjenom injekcionom penu · Amicus SRB D.O.O.Same form

🇸🇬LANTUS 100 Units/ml Solution for injection in a vialSingapore · 100 iu/ml · injection · Sanofi-Aventis Singapore Pte. LTD.Same form

🇸🇬Lantus SoloStar 100 Units/ml Solution for injection in a pre-filled penSingapore · 100 iu/ml · injection, solution · Sanofi-Aventis Singapore Pte. LTD.Same form

🇸🇬Semglee™ Solution for Injection in A Prefilled Pen 100U/MLSingapore · 3.64 mg/ml · injection, solution · Cedar Pharmaceuticals Pte. LTD.Same form

🇧🇷GlargilinBrazil · Biomm SASame substance

🇧🇷GlatusBrazil · Aspen Pharma Indústria Farmacêutica LtdaSame substance

🇪🇺Abasaglar (previously Abasria)European Union · Eli Lilly Nederland B.V.Same substance

🇪🇺LantusEuropean Union · sanofi-aventis Deutschland GmbHSame substance

🇪🇺OndibtaEuropean Union · Gan & Lee Pharmaceuticals Europe GmbHSame substance

🇭🇷AbasaglarCroatiaSame substance

🇭🇷LantusCroatiaSame substance

🇭🇷SemgleeCroatiaSame substance

Documents

The official texts, at the regulator.

Register entryFDA

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Insulin glargine
Strength: 300UNITS/3ML
Dosage form: Injection
Route: Subcutaneous
Register: United States (FDA)
Status: Marketed
Status in the register: Licensed / Rx
Authorised: 15 Nov 2019
Registration: BLA 205692
Marketing authorisation holder: Eli Lilly and Company
Procedure: 351(a)
Supply: Rx

FDA

SemgleeInsulin glargine · 10ML, 3ML · injectable🇺🇸United States

FDALanglaraInsulin glargine · 100UNITS/ML · injectable🇺🇸United States

FDASemgleeInsulin glargine · 100 UNITS/ML · injectable🇺🇸United States

FDALantusInsulin glargine · 300UNITS/3ML · Injection🇺🇸United States

FDALantusInsulin glargine · 500UNITS/5ML · Injection🇺🇸United States

FDASemgleeInsulin glargine · 300UNITS/3ML · Injection🇺🇸United StatesWithdrawn